As per our latest research, the global atrial fibrillation market size in 2024 stands at USD 17.6 billion, reflecting robust industry expansion fueled by rising cardiovascular disease prevalence and technological advancements in treatment modalities. The market is projected to witness a CAGR of 6.8% during the forecast period from 2025 to 2033, reaching an estimated USD 30.7 billion by 2033. This sustained growth trajectory is primarily attributed to increasing geriatric populations, escalating incidence of lifestyle-related risk factors, and continuous innovation in both pharmacological and non-pharmacological interventions for atrial fibrillation. As healthcare systems worldwide prioritize early diagnosis and effective management of arrhythmias, the atrial fibrillation market is poised for significant advancements and adoption of novel therapies.
https://growthmarketreports.co....m/report/atrial-fibr
